Trials / Completed
CompletedNCT03147898
Observational Study Describing the Immune Profile Induced By Pertussis Vaccines
Characterization of Humoral and Cell-Mediated Immune Responses Following a Booster Dose of Pertussis Vaccine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 15 Months – 59 Months
- Healthy volunteers
- Accepted
Summary
This is an observational study designed to describe the immune profile of toddlers and preschoolers with acellular priming after receiving a booster dose of pertussis vaccine.
Conditions
Timeline
- Start date
- 2017-04-12
- Primary completion
- 2018-07-09
- Completion
- 2018-07-09
- First posted
- 2017-05-10
- Last updated
- 2022-04-25
Locations
2 sites across 2 countries: Mexico, Panama
Source: ClinicalTrials.gov record NCT03147898. Inclusion in this directory is not an endorsement.